References
•Akhondzadeh S. (2019). Microbiome and Schizophrenia.Avicenna journal of medical biotechnology,11(4), 269.
•Aneja, J., Singhai, K., & Paul, K. (2018). Very early-onset psychosis/schizophrenia: Case studies of spectrum of presentation and management issues.Journal of family
medicine and primary care,7(6), 1566–1570. https://doi.org/10.4103/jfmpc.jfmpc_264_18
•Graham, L., Marshall, M., & Oritz, R. (2016). Neurobandits : a runaway dopamine molecule that can ’ t be stopped.
•Home. (2024, April 18). https://www.who.int/
•Health News - Medical News Today. (n.d.). https://www.medicalnewstoday.com
•Home. (2024a, April 18). The Pharmaceutical Journal. https://pharmaceutical-journal.com/
•Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2021). The role of the gut microbiome in the development of schizophrenia. Schizophrenia Research,
234, 4–23. https://doi.org/10.1016/j.schres.2020.02.010
•Munawar, N., Ahsan, K., Muhammad, K., Ahmad, A., Anwar, M. A., Shah, I., al Ameri, A. K., & al Mughairbi, F. (2021). Hidden Role of Gut Microbiome Dysbiosis in
Schizophrenia: Antipsychotics or Psychobiotics as Therapeutics? International Journal of Molecular Sciences, 22(14), 7671. https://doi.org/10.3390/ijms22147671
•Morrissette, D. A., & Stahl, S. M. (2011). Affective symptoms in schizophrenia. Drug Discovery Today. Therapeutic Strategies, 8(1–2), 3–9.
https://doi.org/10.1016/j.ddstr.2011.10.005
•NIMH » Home. (2024, April 18). Y. https://www.nimh.nih.gov
•The role of the gut microbiome in the development of schizophrenia. (2021, August 1). ScienceDirect. https://linkinghub.elsevier.com/retrieve/pii/S0920996420300864